Investigating the effect of using GreenNature Deep Lung Support product in COPD patients

Investigating the effect of using the GreenNature Deep Lung Support product on the clinical condition of patients with COPD exacerbation

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200611047727N5

Enrollment

Registered

2023-02-21

Start date

2023-03-21

Completion date

Unknown

Last updated

2023-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic obstructive pulmonary disease. Chronic obstructive pulmonary disease with (acute) exacerbation

Interventions

Intervention 1: Control group: patients in the control group receive a placebo capsule daily. Intervention 2: Intervention group: Patients of this group receive one deep lung support capsule made by D

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: COPD exacerbation grade D Smoking BMI greater than 18 and less than 21

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
AST. Timepoint: The first day and the next ten days. Method of measurement: Laboratory tests.;ALT. Timepoint: The first day and the next ten days. Method of measurement: Laboratory tests.;IL-6. Timepoint: The first day and the next ten days. Method of measurement: Laboratory tests.;Ferritin. Timepoint: The first day and the next ten days. Method of measurement: Laboratory tests.;Procalcitonin. Timepoint: The first day and the next ten days. Method of measurement: Laboratory tests.	—

Measure

Time frame

AST. Timepoint: The first day and the next ten days. Method of measurement: Laboratory tests.;ALT. Timepoint: The first day and the next ten days. Method of measurement: Laboratory tests.;IL-6. Timepoint: The first day and the next ten days. Method of measurement: Laboratory tests.;Ferritin. Timepoint: The first day and the next ten days. Method of measurement: Laboratory tests.;Procalcitonin. Timepoint: The first day and the next ten days. Method of measurement: Laboratory tests.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Sadat Mirenayat

Shahid Beheshti University of Medical Sciences

MirenayaT_M@yahoo.om+98 21 2712 2020

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026